Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia

Abstract Background Neurodegenerative disorders such as Alzheimer’s disease (AD), Parkinson’s disease with dementia (PDD), and dementia with Lewy bodies (DLB) share clinical and molecular features. Cerebrospinal fluid (CSF) biomarkers may help the characterization of these diseases, improving the di...

Full description

Bibliographic Details
Main Authors: Davide Chiasserini, Leonardo Biscetti, Paolo Eusebi, Nicola Salvadori, Giulia Frattini, Simone Simoni, Naomi De Roeck, Nicola Tambasco, Erik Stoops, Hugo Vanderstichele, Sebastiaan Engelborghs, Brit Mollenhauer, Paolo Calabresi, Lucilla Parnetti
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Alzheimer’s Research & Therapy
Subjects:
Cerebrospinal fluid
Biomarkers
Dementia
Heart fatty acid binding protein
Tau
α-Synuclein
Online Access:http://link.springer.com/article/10.1186/s13195-017-0276-4

Internet

http://link.springer.com/article/10.1186/s13195-017-0276-4

Similar Items